semaglutide dove si trova Semaglutide: perché (anche) in Italia rischia l'uso sottobanco Semaglutide e dipendenze: i farmaci

Written By: Pharmacally Medical News DeskNovo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025

misaligned logo

With one capsule daily after a main meal, this formula provides two powerful and effective botanicals to help you feel full faster and stay full longer.*

Compare weight loss treatment options with clear pricing, prescription support and ongoing check-ins from CheqUp.

From study baseline to the end of follow-up, GLP-1RAs treatment resulted in statistically significant decreases in weight (MD=-2.32 kg, 95% CI: -4.21 to -0.43) and BMI (MD=-0.82 kg/m2, 95% CI: -1.47 to -0.17)